Skip to main content
Log in

Preventable Deaths Involving Medicines: A Systematic Case Series of Coroners’ Reports 2013–22

  • Original Research Article
  • Published:
Drug Safety Aims and scope Submit manuscript

Abstract

Introduction

Medicines cause over 1700 preventable deaths annually in England. Coroners’ Prevention of Future Death reports (PFDs) are produced in response to preventable deaths to facilitate change. The information in PFDs may help reduce medicine-related preventable deaths.

Objectives

We aimed to identify medicine-related deaths in coroners’ reports and to explore concerns to prevent future deaths.

Methods

We carried out a retrospective case series of PFDs across England and Wales, dated between 1 July, 2013 and 23 February, 2022, collected from the UK’s Courts and Tribunals Judiciary website using web scraping, generating an openly available database: https://preventabledeathstracker.net/. We used descriptive techniques and content analysis to assess the main outcome criteria: the proportion of PFDs in which coroners reported that a therapeutic medicine or drug of abuse had caused or contributed to a death; the characteristics of included PFDs; coroners’ concerns; the recipients of PFDs; and the timeliness of their responses.

Results

There were 704 PFDs (18%; 716 deaths) that involved medicines, representing an estimated 19,740 years of life lost (average of 50 years lost per death). Opioids (22%), antidepressants (9.7%), and hypnotics (9.2%) were the most common drugs involved. Coroners expressed 1249 concerns, primarily around the major themes of patient safety (29%) and communication (26%), including minor themes of failures of monitoring (10%) and poor communication between organizations (7.5%). Most expected responses to PFDs (51%; 630/1245) were not reported on the UK’s Courts and Tribunals Judiciary website.

Conclusions

One in five coroner-reported preventable deaths involved medicines. Addressing coroners’ concerns, including problems with patient safety and communication, should reduce harms from medicines. Despite concerns being raised repeatedly, half of the PFD recipients failed to respond, suggesting that lessons are not generally learned. The rich information in PFDs should be used to foster a learning environment in clinical practice that may help reduce preventable deaths.

Clinical Trial Registration

https://doi.org/10.17605/OSF.IO/TX3CS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Taylor S, Annand F, Burkinshaw P, Greaves F, Kelleher M, Knight J, et al. Dependence and withdrawal associated with some prescribed medicines: an evidence review. London: Public Health England; 2019.

  2. Kingston A, Robinson L, Booth H, Knapp M, Jagger C, Adelaja B, et al. Projections of multi-morbidity in the older population in England to 2035: estimates from the Population Ageing and Care Simulation (PACSim) model. Age Ageing. 2018;47:374–80. https://doi.org/10.1093/ageing/afx201.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Lichtenberg FR. How many life-years have new drugs saved? A three-way fixed-effects analysis of 66 diseases in 27 countries, 2000–2013. Int Health. 2019;11:403–16. https://doi.org/10.1093/inthealth/ihz003.

    Article  PubMed  Google Scholar 

  4. Montané E, Arellano AL, Sanz Y, Roca J, Farré M. Drug-related deaths in hospital inpatients: a retrospective cohort study. Br J Clin Pharmacol. 2018;84:542–52. https://doi.org/10.1111/bcp.13471.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Pardo Cabello AJ, del Pozo GE, Gómez Jiménez FJ, Mota Rodríguez C, Luna Del Castillo JDD, Puche CE. Drug-related mortality among inpatients: a retrospective observational study. Eur J Clin Pharmacol. 2016;72:731–6. https://doi.org/10.1007/s00228-016-2026-0.

    Article  CAS  PubMed  Google Scholar 

  6. Elliott RA, Camacho E, Jankovic D, Sculpher MJ, Faria R. Economic analysis of the prevalence and clinical and economic burden of medication error in England. BMJ Qual Saf. 2020;30:96–105. https://doi.org/10.1136/bmjqs-2019-010206.

    Article  PubMed  Google Scholar 

  7. Coroners and Justice Act 2009. Statute Law Database; 2009.

  8. The Coroners Rules 1984. 552 United Kingdom. 1 July, 1984. https://www.legislation.gov.uk/uksi/1984/552/article/6/made. Accessed 28 Jan 2023.

  9. The Coroners (Investigations) Regulations 2013. Queen’s Printer of Acts of Parliament; 2013.

  10. Ferner RE, Easton C, Cox AR. Deaths from medicines: a systematic analysis of coroners’ reports to prevent future deaths. Drug Saf. 2018;41:103–10. https://doi.org/10.1007/s40264-017-0588-0.

    Article  PubMed  Google Scholar 

  11. Anis A, Heneghan C, Aronson JK, DeVito NJ, Richards GC. Deaths from cardiovascular disease involving anticoagulants: a systematic synthesis of coroners’ case reports. BJGP Open. 2022;6(1):BJGPO.2021.0150.

    PubMed  Google Scholar 

  12. Aronson JK, Ferner RE, Richards GC. Deaths attributed to the use of medications purchased online. BMJ Evid Based Med. 2022;27:60–4. https://doi.org/10.1136/bmjebm-2021-111759.

    Article  PubMed  Google Scholar 

  13. France HS, Richards GC, Aronson JK, Ferner R, Cox AR, Heneghan C. Pre-registration of Preventable deaths involving medicines and misused drugs: a systematic analysis of coroners’ case reports in England and Wales 2019–2021. OSF; 2021. https://doi.org/10.17605/OSF.IO/TX3CS. Accessed 11 Sep 2022.

  14. Prevention of Future Deaths | Subjects | Courts and Tribunals Judiciary. 2022. https://www.judiciary.uk/subject/prevention-of-future-deaths/. Accessed 2 Feb 2022.

  15. DeVito NJ, Richards GC, Inglesby P. How we learnt to stop worrying and love web scraping. Nature. 2020;585:621–2. https://doi.org/10.1038/d41586-020-02558-0.

    Article  CAS  PubMed  Google Scholar 

  16. Richards GC. Preventable deaths tracker. https://preventabledeathstracker.net/the-database/. Accessed 28 Jun 2021.

  17. Joint Formulary Committee. British National Formulary. 82nd ed. BMJ Group, editor. London: British Medical Association and Royal Pharmaceutical Society of Great Britain; 2021.

  18. IUPHAR. IUPHAR/BPS guide to pharmacology. 2021. https://www.guidetopharmacology.org/. Accessed 28 Sep 2021.

  19. Misuse of Drugs Act 1971. Statute Law Database; 1971.

  20. Buxton J. Life expectancy in the UK: 2018 to 2020. Office for National Statistics. 2021.

  21. World Health Organization. Years of life lost (YLL) (per 100 000 population). Global Health Observatory. 2006. https://www.who.int/data/gho/indicator-metadata-registry/imr-details/4427. Accessed 25 Nov 2021.

  22. Hsieh H-F, Shannon SE. Three approaches to qualitative content analysis. Qual Health Res. 2005;15(9):1277–88. https://doi.org/10.1177/1049732305276687.

    Article  PubMed  Google Scholar 

  23. Leary A, Bushe D, Oldman C, Lawler J, Punshon G. A thematic analysis of the prevention of future deaths reports in healthcare from HM coroners in England and Wales 2016–2019. J Patient Saf Risk Manag. 2021;26:14–21. https://doi.org/10.1177/2516043521992651.

    Article  Google Scholar 

  24. Richards GC. Deaths from cardiovascular disease involving anticoagulants. Github; 2021.

  25. France HS, Richards GC. OSF: preventable deaths involving medicines and misused drugs: a systematic analysis of coroners’ case reports in England and Wales 2013-2021. OSF; 2021. https://osf.io/wq7g5/. Accessed 15 Feb 2022.

  26. France H. Pandemics, pharmacology, and preventable deaths. London: Pharmacology Matters, British Pharmacological Society; 2022.

    Google Scholar 

  27. Semple L, Gamblin N. Avoidable mortality in Great Britain: 2020. 2022.

  28. Walters S. Coroners statistics 2019: England and Wales. 2019. https://www.gov.uk/government/statistics/coroners-statistics-2019/coroners-statistics-2019-england-and-wales. Accessed 28 Jan 2023.

  29. Coronial Services of New Zealand. Coronial Services of New Zealand Regulations. 2022. https://coronialservices.justice.govt.nz/coronial-services/. Accessed 3 Feb 2022.

  30. Coroners Court of Victoria. Coroners Court of Victoria Regulations. https://www.coronerscourt.vic.gov.au/. Accessed 3 Feb 2022.

  31. State Coroner’s Court of New South Wales. Coroners Court of New South Wales Regulations. 2022. https://www.coroners.nsw.gov.au/. Accessed 3 Feb 2022.

  32. Office of the Chief Coroner. Ontario Ministry of Community Services and Correctional Services. Coroners Act 1990. 37 Canada. 19 April, 1990. https://www.ontario.ca/laws/statute/90c37. Accessed 28 Jan 2023.

  33. Swift B, Heneghan C, Aronson J, Howard D, Richards GC. Preventable deaths from SARS-CoV-2 in England and Wales: a systematic case series of coroners’ reports during the COVID-19 pandemic. BMJ Evid Based Med. 2022;27(5):296–304. https://doi.org/10.1136/bmjebm-2021-111834.

    Article  PubMed  Google Scholar 

  34. Ferner RE, Ahmad T, Babatunde Z, Cox AR. Preventing future deaths from medicines: responses to coroners’ concerns in England and Wales. Drug Saf. 2019;42:445–51. https://doi.org/10.1007/s40264-018-0738-z.

    Article  PubMed  Google Scholar 

  35. Aaronson EL, Brown D, Benzer T, Natsui S, Mort E. Incident reporting in emergency medicine: a thematic analysis of events. J Patient Saf. 2019;15:E60–3. https://doi.org/10.1097/PTS.0000000000000399.

    Article  PubMed  Google Scholar 

  36. Mclean M, Roach J, Armitage R. Local variations in reporting deaths to the coroner in England and Wales: a postcode lottery? J Clin Pathol. 2013;66:933–6. https://doi.org/10.1136/jclinpath-2013-201640.

    Article  PubMed  Google Scholar 

  37. Fox AW, Jacobson J. How well do Regulation 28 reports serve future public health and safety? Med Sci Law. 2021;61:186–92. https://doi.org/10.1177/0025802420987431.

    Article  PubMed  Google Scholar 

  38. King R, Benbow EW. Are the recommendations in coronial prevention of future death (PFD) reports realistic and achievable? Med Leg J. 2022;90:27–31. https://doi.org/10.1177/00258172211059905.

    Article  PubMed  Google Scholar 

  39. Richards GC, Aronson JK, Heneghan C. Coroners’ concerns to prevent harms: a series of coroners’ case reports to serve patient safety and educate the public, clinicians and policy-makers. BMJ Evid Based Med. 2021;26:37–8. https://doi.org/10.1136/bmjebm-2020-111567.

    Article  PubMed  Google Scholar 

  40. Richards GC, Anthony G, Aronson JK, Heneghan C, Goldacre B. Preventable suicides: a systematic analysis of coroners’ prevent future death reports in England and Wales. OSF; 2020. https://osf.io/ad4up/. Accessed 14 Jun 2021.

  41. Richards GC, Aronson JK, Ferner RE, Cox AR, Heneghan C, Goldacre B, et al. Preventable opioid-related deaths: a systematic analysis of coroners’ reports. OSF; 2019. https://osf.io/ecz4r/. Accessed 14 Jun 2021.

  42. Karolina Bilip M, Richards GC. Emollients and smoking: a fire hazard that could be prevented to reduce future deaths. BMJ Evid Based Med. 2021;26:131–4. https://doi.org/10.1136/bmjebm-2020-111648.

    Article  Google Scholar 

  43. Richards GC. Alcohol-based hand sanitisers: a warning to mitigate future poisonings and deaths. BMJ Evid Based Med. 2021;26:65–8. https://doi.org/10.1136/bmjebm-2020-111568.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Harrison S. France.

Ethics declarations

Funding

No funding was obtained for this study. An Engagement and Dissemination grant (2020) and Seedcorn funding (2021) was obtained from the National Institute of Health Research (NIHR) School for Primary Care Research to develop the Preventable Deaths Tracker website: https://preventabledeathstracker.net/.

Conflicts of Interest/Competing Interests

All authors have completed the ICMJE uniform disclosure form at http://www.icmje.org/disclosure-of-interest/ and declare no support from any organization for the submitted work. HSF has received scholarships (2020–22) from Brasenose College, University of Oxford and Fidelity National Information Services for undergraduate study, from the British Pharmacological Society (2022) for meritorious performance in a research competition and received payments (2022) from Brasenose College, University of Oxford for undergraduate teaching. JKA has published papers in bioscience journals and edited textbooks on adverse drug reactions; he has often acted as an expert witness in civil actions relating to suspected adverse drug reactions and in coroners’ courts. CH holds grant funding from the NIHR, the NIHR School of Primary Care Research. CH has received expenses and fees for his media work, for teaching EBM and is also paid for his GP work in the National Health Service out of hours (contract Oxford Health National Health Service Foundation Trust). CH is the Director of the Centre for Evidence-based Medicine. REF has undertaken research and published on adverse drug reactions and medication errors. REF has acted as an expert witness in coronial and other legal cases related to these. ARC holds grant funding from Cancer Alliance. ARC has received fees for media work, a scientific advisory committee at IQVIA, and external examinations at UK Universities. ARC is the Head of the School of Pharmacy at the University of Birmingham and is an honorary pharmacovigilance pharmacist at the West Midlands Centre for Adverse Drug Reaction Reporting. GCR is the director of a limited company that is independently contracted to work as an epidemiologist and teach at the University of Oxford. GCR received scholarships (2017–20) from the National Health Service NIHR School for Primary Care Research, the Naji Foundation, and the Rotary Foundation to study for a DPhil at the University of Oxford. The study guarantor affirms that the article is an honest, accurate, and transparent account of the study being reported; that no important aspects of the study have been omitted; and that any discrepancies from the study as planned and registered have been explained.

Ethics Approval

This study exclusively uses publicly available information, for which ethics committee approval is not required.

Consent to Participate

Patient consent was not sought for this study, which exclusively used publicly available information regarding deceased individuals.

Consent for Publication

Not applicable.

Availability of Data and Material

All study materials, data, and statistical code are openly available via online repositories. The study protocol was preregistered on the OSF (https://doi.org/10.17605/OSF.IO/TX3CS); the code to generate the database and the Preventable Deaths Tracker is openly available via GitHub (https://github.com/georgiarichards/georgiarichards.github.io); individual Prevention of Future Deaths reports are available on the Courts and Tribunals Judiciary website (https://www.judiciary.uk/prevention-of-future-death-reports/); and all other study materials are openly available via the OSF project page (https://doi.org/10.17605/OSF.IO/WQ7G5).

Code Availability

The code to generate the database and the Preventable Deaths Tracker is openly available via GitHub (https://github.com/georgiarichards/georgiarichards.github.io).

Author contributions

HSF updated the study protocol, carried out screening of PFDs, extracted remaining data, conducted all analyses, produced all figures and tables, and wrote the first draft of the manuscript. GCR conceptualized, designed, and initiated the study; provided supervisory support, and edited the first draft of the manuscript. REF and ARC contributed to the study conceptualization. CH and JKA provided supervisory support and oversight. REF and JKA provided clinical pharmacological advice and interpretation. All study authors read, contributed to, and approved the final manuscript. HSF is the guarantor. The corresponding author attests that all listed authors meet authorship criteria and that no others meeting the criteria have been omitted.

Additional information

Preprint uploaded to MedRxiv. Available at: https://doi.org/10.1101/2022.11.01.22281803.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (PDF 1285 kb)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

France, H.S., Aronson, J.K., Heneghan, C. et al. Preventable Deaths Involving Medicines: A Systematic Case Series of Coroners’ Reports 2013–22. Drug Saf 46, 335–342 (2023). https://doi.org/10.1007/s40264-023-01274-8

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40264-023-01274-8

Navigation